Long term effects of dilazep hydrochloride, an anti-platelet drug, on patients with IgA nephropathy - Reports of 5-year treatment

Current Topics in Pharmacology

Volumn 11, Issue 1, 2007, Pages 45-49

  Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dilazep hydrochloride; IgA nephropathy

Indexed keywords

COMERIAN; DILAZEP; UNCLASSIFIED DRUG;

CREATININE CLEARANCE; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE URINE LEVEL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN URINE LEVEL; SHORT SURVEY; SIDE EFFECT; TISSUE INJURY; TREATMENT DURATION; URINARY EXCRETION; URINE SEDIMENT;

EID: 56749138242     PISSN: 09724559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Gohda, T., Makita, Y., Shike, T., Funabiki, K., Horikoshi, S., Shirato, I., and Tomino, Y. 2000, Nephron, 84, 90.
2. Tomino, Y., Sakai, H. 2003, Clin. Exp. Nephrol., 7, 93.
3. Hayashi, T., Kaneko, S., Thng, N. T., Shou, I., Shirato, I., and Tomino, Y. 2000, Nephron, 86, 327.
4. Nakazawa, K, Moriya, T., Kasai, S., Yamazaki, T., Komiyama, Y., Shigematsu, H., Akiba, T., Koga, T. 1993, Jpn. J. Nephrol., 35, 329.
5. Nagase, M., Kobayashi, D., and Sakakibara, K. 1985, Jpn. J. Nephrpl., 27, 385.
6. Yamamoto, M., Fukui, M., Kuramoto, T., Kabuki, K., and Tomino, Y. 1995, J. Clin. Lab. Anal., 9, 380.
7. Tomino, Y., Suzuki, H., Horikoshi, S., Imai, E., Miyazaki, M., Ohzono, Y., Harada, T., Yoshida, H., Kawamura, T., Kobayashi, Y., Suzuki, S., Nitta, K., Hotta, O., Yoshikawa, N., Endoh, M., and Sakai, H. 2004, Current Topics in Steroid Research, 4, 93.
8. Yukimura, T., Miura, K., Ito, K., and Yamamoto, K. 1986, J. Cardiovasc. Pharm., 8, 649.